Blog Overview

To better serve growing demand in the region, Carta is bolstering its already established presence with additional resources, capabilities, and partnerships.

The CEO of Reunion Neuroscience, a company developing a drug to treat postpartum depression and mental health distress related to cancer, took a unique approach to advance company goals.

This integration allows shared customers with our partners to draft option grants and generate legal documents for issuing equity directly from the Carta dashboard.

From traditional startup hubs to emerging entrepreneurial ecosystems across the country, these ventures are fueling employment opportunities, reshaping the American economy, and leading to our competitive edge.

Morgan Stanley at Work to become Carta’s preferred U.S. public equity management platform, aligning world-class cap table management and IPO readiness with public equity compensation solutions and wealth management.

Now, you can view your company's status for 409A valuation, QSBS eligibility, Form 3921, and more—all from a single, actionable dashboard. Think of it as your command center for compliance.